Constitutive pathway activation, through mutation or overexpression of JAK1, JAK3, STAT3, STAT5, and the common gamma chain, have been reported in PTCL and shown to be oncogenic [11, 15, 31–34]. Here, JAK3 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.